Novel automatic treatment instrument for respiratory tract specimen

Abstract

The invention relates to a novel automatic treatment instrument for a respiratory tract specimen, belonging to the field of relevant automatic instruments for treatment of the respiratory tract specimen before examination in clinical medicine. The instrument not only has the functions of automatically completing the digestion (liquefaction) of the respiratory tract specimen to be examined, centrifugal concentration and separation of bacteria and pathologic cells, but also can conduct treatment such as automatic inoculation and culture or slide dying and the like respectively or simultaneously to the concentrated pathogenic and the pathologic cells. The instrument additionally has the functions of automatic temperature increase, automatic agitation and the like which can promote specimen treatment. Moreover, the internal part of the instrument can be automatically disinfected.

Description

1. Technical field [0001] The invention relates to the field of related automatic instruments for performing pre-examination treatment on respiratory tract specimens (secretion, sputum) to be inspected in clinical medicine. 2. Background technology [0002] Direct inspection of respiratory samples (secretion, sputum) is an important diagnostic method for the diagnosis of many respiratory diseases. For example, direct detection of Mycobacterium tuberculosis or the detection of Mycobacterium tuberculosis gene DNA molecules in such samples is the most critical and reliable method for the diagnosis of pulmonary tuberculosis. in accordance with. Pre-testing respiratory samples and effectively concentrating pathogenic bacteria or pathological cells is an important link to improve the quality and efficiency of testing. At present, the pre-processing of respiratory samples still relies on manual operations, and some inspection units do not even process the samples and directly smea...

AI Technical Summary

Problems solved by technology

At present, the pre-processing of respiratory samples still relies on manual operations, and some inspection units do not even process the samples and directly smear or directly inoculate respiratory samples, resulting in a low detection rate

Manual pre-treatment of respiratory samples is cumbersome and inefficient, and the quality is not easy to control. There is a high risk of infection for the operator and affects the enthusiasm of the operator.

All these factors lead to a low positive detection rate, which not only delays the diagnosis and treatment of patients, but also leads to the loss of control of the source of infection due to missed diagnosis of infectious respiratory diseases such as tuberculosis, causing serious harm to public health and social security.

Images